Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
- Status
- UNKNOWN
- Phase
- N/A
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
- Status
- TERMINATED
- Phase
- PHASE1
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
- Status
- COMPLETED
- Phase
- N/A
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
- Status
- COMPLETED
- Phase
- N/A
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
- Status
- TERMINATED
- Phase
- PHASE1
Infusion of Expanded Cord Blood T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study for Leukemia Patients With Life-Threatening Infections
- Status
- COMPLETED
- Phase
- PHASE3
Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders
- Status
- WITHDRAWN
- Phase
- PHASE1
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2